Securus Technologies is a top company in the public service industry offering innovative solutions to ensure public safety. Currently, the corporation focuses on civil and criminal justice technological solutions that solve and prevent crimes including prisoner-to-prisoner crimes. Securus Technologies has its main offices in Dallas, TX. Statistics reveal that it serves approximately 3,450 stakeholders in public safety, law enforcement, jails as well as 1.2 million prisoners in North America
On January 2016, Securus Technologies employed John Bell to work as the Senior Vice President of Sales. In a Statement, Rick Smith, the CEO of Securus Technologies declared that the company had capitalized $600 million in acquiring safety, efficiency and security technology since 2013. As a result, the company needed to hire key sales individual with the experience necessary to manage the transforming and evolving sales team and make proper use of the investment.
Rick Smith further elucidated that John Bell was more than qualified in his 35-year profession during which he had gained the perfect track record in transforming organizational culture and performance. Moreover, John Bell also has an excellent educational background having studied at Holy Cross with postgraduate work at the Wharton School of Business and the Kellogg School of Management. Mr. Bell has also worked at notable technological firms including IBM, Verizon, Time Warner Cable, NTT Verio, and AT&T making him the best candidate for the position.
According to the Smith, Mr. Bell was supposed to work with the rest of the sales teams at Securus to ensure that the corporation will never lose a contract with its stakeholders. This is because the team will get a better understanding of the newly acquired technology and as a result will present them effectively to the clients. Visit securustechnologies.com for more info.
Rick Smith in a statement proclaiming that Securus Technologies was a profitable investment that released innovations on a weekly basis to aid the police and prison agencies to solve crimes as well as prevent the occurrence of wrongdoings. He went on to further elucidate that the company had received numerous letters and emails from customers detailing their appreciation with regards to the usefulness of Securus Technologies Products. The client comments were an actual indication that Securus Technologies was transforming people’s lives for the better. For instance, one of the comments was from a prison representative who was ecstatic that Securus had aided them to apprehend a corrupt prison staff. Another customer from the Sheriff’s Department was satisfied that the LBS software had enabled them to recover a lot of money laundered as assets, cash, and drugs. Rick concluded that he was happy that Securus was accomplishing its objective of safeguarding and serving the public community. Read more on glassdoor.com about Rick Smith Securus.
JeanMarie Guenot, Ph.D is the President and CEO of Amphivena Therapeutics, and is actively working to develop antibody therapies to help combat blood and bone marrow tumors and cancers. With experience in both the fields of business/venture capital as well as in Biological R&D, and a Ph.D from the University of California San Francisco, she is a force to be reckoned with in the business of biochemical research.
Prior to her current position, JeanMarie Guenot built up SKS Ocular, a start-up focusing on medications and other therapies for health of the eyes. She also served as a business advisor for Hoffmann-La Roche, and was nominated Vice-President of Corporate and Business Development at the firm PDL BioPharma, leading administrative tasks. Awards received by Dr. Guenot are including a 2005 BioBusiness Network’s Innovative Bio-Partnering Award as well as a 2006 Licensing Executives Society’s Deal of Distinction Award. Her portfolio consists of experience and developments in Oncology, Cardiovascular diseases, autoimmune diseases, ophthalmic diseases and neurology. She also oversaw the Biogen Idec-PDL Biopharma, 50:50 co-development and co-commercialization strategic collaboration effort, an $800 Million transaction which involved three Phase Two cancer and autoimmune disease drug candidates on takeda.com.
The goal of the therapies being developed by Amphivena Therapeutics is to reduce the collateral damage of cancer-fighting drugs by harnessing the body’s own white blood cell defenses to combat cancer growth. This has incredible significance in the realm of blood cancers, due to the widespread distribution of the illness and hence the widespread damage if cancer-killing drugs were to be used. According to guenotllc.com, the firm, and Dr. Guenot, believe that within 5 years their firm will have synthesized a drug earmarked to tackle hard to beat, entrenched blood cancers.
With a relatively broad social media presence, from LinkedIn at https://www.linkedin.com/in/jeanmarie-guenot-4a140617 to her own personal website, she shares her biography and her accomplishments with a good amount of media outlets. A few very important milestones were made in 2015, signaling the firm with her at the helm is close to some important breakthroughs. Cancer effects people from all walks of life. Hopefully, JeanMarie is close to decisively beating it back.
Arthur Becker is an excellent administrator who has made significant accomplishments in his career. He currently acts as the managing director of Madison Partners LLC. Mr. Becker leads the company in conducting its real estate and biotechnology ventures. He has had a successful career. Arthur Becker had severed various organizations before he was hired by Madison Partners LLC. He once acted as the chairperson and CEO of Zinio, which is a popular digital newsstand. Becker held the office for about three years, and his term ended in 2015. Before being hired by Zinio, how worked at Navisite where he was the CEO.
Navisite is a firm that that has majored in offering various internet services. It has also focused on the provision of various technology solutions such as hosting. The main client base of the company was in the United States and the United Kingdom when Arthur joined it. Under his leadership, it managed to attract customers from Canada and India. Arthur Becker has also worked for a fashion enterprise that was known as Vera Wang Fashion. He has been at the firm for more than seven years now. Click here to know more.
Mr. Becker says that he is currently not as busy as he used to be when he was an employee of Zinio and Navisite. He now has sufficient time to venture into his personal businesses such as the development of the Town Houses on Sullivan Street in New York City. Arthur is now planning to construct a luxurious condominium that will be located in the Tribeca region. He has been working with respectable individuals in ensuring that his projects are successful in the financing and development stages. Arthur believes in organization and coordination in completing the undertakings that he has started. According to him, the primary challenge that people face is the ability match the critical the thinking, desire, and passion. Arthur Becker believes that success comes gradually in every field. He refers to it as a journey and no a destination. His way to being a top corporate leader was faced with several obstacles, but he strived and managed to overcome them. Becker is determined to making Madison Partners LLC a highly profitable enterprise.